Joseph K. Belanoff - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Corcept Therapeutics Incorporated (CORT)

Filing Manager: BELANOFF JOSEPH K
Reporting Manager: Joseph K. Belanoff
Security: Corcept Therapeutics Incorporated Common Stock
Symbol: CORT
Shares outstanding: 108M shares
Disclosed Ownership: 6.82M shares
Ownership: 6.3%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 09:08 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Joseph K. Belanoff	6.3%	6.82M	3.8M	3.02M	/s/ Joseph K. Belanoff	Chief Executive Officer